Hims Hers Stumbles Open as Regulatory Damage Hits Outlook
Hims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
Learn the key factors that contribute to a reliable dividend stock. Make informed investment choices for steady income.
20,247 articlesHims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
Snowflake delivered strong Q4 revenue but faces securities lawsuits and an looming April 27 deadline, creating a mixe...
Pulmonx is navigating a pivotal year as it advances its lung care devices while contending with pacing competition an...
Circle led a broad crypto-stock rally on Monday, with shares up near 10% as Bitcoin rallied and stablecoin momentum b...
A veteran financial journalist breaks down abacus global (abx) 2025 Q4 results, explains what the numbers mean for 20...
As 2025 earnings season hits, savvy investors need a clear playbook for cibus (cbus) 2025 earnings. This guide breaks...
FELG has fallen about 8% year-to-date as megacap tech leads a broad pullback in growth stocks. The ETF tracks fidelit...
NVIDIA delivered blockbuster AI-focused results that strengthen a nvidia buy thesis, while Palantir faces valuation h...
Legendary investor Paul Tudor Jones warns that the Trump-era market boom could end in a 30-35% correction, even as he...
Major banks reduced their Figma price targets even as the company posted rapid revenue growth, signaling that AI comp...
As investors eye pagseguro (pags) 2026 earnings, this guide breaks down what to watch, how growth could unfold, and p...
Jim Cramer defies the pullback, urging investors to buy DoorDash despite a roughly 30% year-to-date drop. The call hi...